Keywords :   







News category:

Biotechnology and Pharmaceuticals


KEYTRUDA (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

2016-12-07 08:45:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. First Presentation of Patient-Reported Outcomes from KEYNOTE-024 Study of Patients with Metastatic NSCLC Whose Tumors Have High PD-L1 Expression (Tumor Proportion Score [TPS] of 50 Percent or More) Findings Presented in Plenary Session at 17 th World Conference on Lung Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced positive health-related quality of life (HRQoL) findings from an exploratory analysis from the phase 3 KEYNOTE-024 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, compared to standard of care (SOC) platinum-containing chemotherapy for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 (tumor proportion score [TPS] of Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more

Tags: life quality cell treatment

Category: Biotechnology and Pharmaceuticals
 

Updated KEYTRUDA (pembrolizumab) Data in Small Cell Lung Cancer and Mesothelioma Presented at 17th World Conference on Lung Cancer

2016-12-06 14:20:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Findings in Small Cell Lung Cancer and Malignant Pleural Mesothelioma Show Overall Response Rates of 33.3 Percent and 20.0 Percent, Respectively, in KEYNOTE-028 Long-Term Data Demonstrate Durable Responses in Difficult-to-Treat Cancers KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that updated findings from the phase 1b KEYNOTE-028 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in previously treated patients with advanced small cell lung cancer (SCLC) and malignant pleural mesothelioma, showed clinical activity and durable responses in some patients. Language: English Contact: Media:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestorsTeri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more

Tags: on world data small

Category: Biotechnology and Pharmaceuticals
 

Merck to Participate at the Citi 2016 Global Healthcare Conference

2016-12-06 14:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, is scheduled to participate at the Citi 2016 Global Healthcare Conference in New York on Dec. 7, 2016 at 12:35 p.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://investors.merck.com/investors/webcasts-and-presentations/default.aspx. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more

Tags: global conference participate healthcare

Category: Biotechnology and Pharmaceuticals
 

Consumer Goods and Services


Faster house price growth in November, says the Halifax

2016-12-07 10:44:51| BBC News | Business | UK Edition

Annual growth in UK house prices accelerated for the first time in eight months in November, a lender's figures show.

Tags: the price november house

Category: Consumer Goods and Services
 

Italy bank shares rise on bailout hopes

2016-12-07 10:29:15| BBC News | Business | UK Edition

Italian bank shares rise further after falling in response to the government's referendum defeat.

Tags: bank italy rise shares

Category: Consumer Goods and Services
 

Apple says iPhones safe despite China fires

2016-12-07 10:26:58| BBC News | Business | UK Edition

Apple has blamed "external factors" for a handful of iPhone battery fires in China.

Tags: china safe apple fires

Category: Consumer Goods and Services
 

Electronics and Electrical


Electrical Cable Failure: The Trillion Dollar Question

2016-12-06 19:15:00| Transmission & Distribution World

Sponsored Content by AVO Training A trillion dollars is likely a conservative estimate when you consider the magnitude of the power cable issues in the U.S. It has been known for some time that the cable systems in the U.S. have reached and in many cases exceeded their life expectancy.  Let’s face it, wholesale replacement of an underground cable installation is expensive, time consuming and many times results in off hour scheduling and clearances requiring customers to be without power during reconnection of power to theinstallation. read more

Tags: question cable failure dollar

Category: Electronics and Electrical
 

Product Combines Fuse Tool, Voltage Detector and Flashlight

2016-12-06 18:03:00| Transmission & Distribution World

HD Electric Co. has launched its FireFly Fuse Tool Voltage Detector. read more

Tags: product tool voltage combines

Category: Electronics and Electrical
 

Justifying Utility Security Investments

2016-12-06 17:50:00| Transmission & Distribution World

Justifying Utility Security Investments read more

Tags: security utility investments security utility

Category: Electronics and Electrical